CITN11-02 interim trial results: subcutaneous...

CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells

Morishima, Chihiro, McNeel, Douglas G, Patel, Manish R, Kohrt, Holbrook E, Waldmann, Thomas A, Thompson, John A, Conlon, Kevin C, Sondel, Paul M, Wakelee, Heather A, Apodaca, Minjun C, Fling, Steven P
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
3
Year:
2015
Language:
english
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1186/2051-1426-3-S2-P203
File:
PDF, 253 KB
english, 2015
Conversion to is in progress
Conversion to is failed